(MedPage Today) — Prostate-specific antigen (PSA) testing for prostate cancer may be targeted to men unlikely to benefit from the test, including those age 70 and older, according to a U.K. study.
Contrary to recommendations regarding age and…
Source link : https://www.medpagetoday.com/hematologyoncology/prostatecancer/117871
Author :
Publish date : 2025-10-09 18:40:00
Copyright for syndicated content belongs to the linked Source.
